Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion type Assertion NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_head.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion description "[36.6% of the patients with MDS and myelofibrosis developed a transformation into ANLL during the course of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_provenance.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion evidence source_evidence_literature NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_provenance.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion SIO_000772 1592101 NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_provenance.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion wasDerivedFrom befree-2016 NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_provenance.
- NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_assertion wasGeneratedBy ECO_0000203 NP496754.RA1-Aw0gBxI20N5GchdWxzcVx8YUGep4IrZ2LDLBXAd04130_provenance.